Puma Biotechnology (PBYI)
(Delayed Data from NSDQ)
$4.79 USD
-0.04 (-0.83%)
Updated May 9, 2024 04:00 PM ET
After-Market: $4.79 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $0.11 | -165.62% |
Earnings Summary
For their last quarter, Puma Biotechnology (PBYI) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.16 per share. This reflects a positive earnings surprise of 68.75%. Look out for PBYI's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of $0.11 per share, reflecting a year-over-year increase of 10%.
Earnings History
Price & Consensus
Zacks News for PBYI
Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates
PBYI: What are Zacks experts saying now?
Zacks Private Portfolio Services